# XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study

> **NCT00631228** · — · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 1000 (actual)

## Conditions studied

- Coronary Disease
- Coronary Artery Disease
- Coronary Restenosis

## Interventions

- **DEVICE:** XIENCE V® Everolimus Eluting Coronary Stent

## Key facts

- **NCT ID:** NCT00631228
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-04
- **Final completion:** 2012-08
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2012-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00631228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00631228, "XIENCE V® Everolimus Eluting Coronary Stent System India Post-marketing Single-arm Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00631228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*